natalie chacon Review of Novartis de Venezuela SA.
good afternoon friends, the following is to publis...
good afternoon friends, the following is to publish, something that is happening with this laboratory and its inadresponsibility to patients who should be given the medicine called leponex, they tell us they do not have this medication, for all the events that happened in the country , of course we understand it and we know that the situation is extremely complicated, call currency granting, customs and other resources that make this very difficult agility and management for the repositioning of all medicines in Venezuela, thanks to the large and extraordinary policies of the country, with all my respect, is that I do not understand that knowing all these problems did not occur there a contingency plan for said medication (leponex). This is a drug called psychotropic, for people who have various types of brain problems and is very important for the healthy peace of the patient, they require us to make the patient a monthly examination of hematology for them to verify that certain values are in their level and be able to authorize the sale of the drug, if otherwise those values are below the specified range the drug can not be supplied, so dangerous and delicate is to ingest it, complementing the information is a psychotropic that not being provided in their specific doses and especially continuous, to fail one and maximum two days will not be able to supply more during the life of that patient that drug, my question, where is the responsibility of this laboratory knowing the delicate and handling of said product, marketed only by they, what happens with the patients and said responsibility on them, are around 20 years that leponex is in the market, Are the patients? how much is the dose for each one? How many years of supply? only they know it, besides the many laboratory tests and the visit in some cases of nurses to the homes of many patients due to their condition, plus a restricted schedule for this authorization of only half a day, making the management more complicated, in end many regulations, discomforts and calamities that must be said by the patient and his family, so that they then wash their hands and tell us quietly that there is no medication that is easy, talk to your doctor and give us the answer. What is my question? I think it is a psychotropic that is sold worldwide and on a large scale, it is lost in Venezuela, there is no profit, the margin does not give to dispatch, I still wonder what is the laboratory's support for us? apparently none, do not care, everything has been a secrecy, could have warned with time, an announcement, nothing. what measures can be taken against this laboratory that says to be called novartis de venezuela, when it does not assume its responsibility towards its patients. indemnity to patients, legal advice, more information about these cases, something must be done. you hear suggestions to try to solve this problem in the short term, thank you.
Comments: